VSIR and cancer: The V-set immunoregulatory receptor (VSIR) is a recently identified novel member of the B7 immune checkpoint (IC) family of immunoregulatory genes (Wang et al. 2011) and has emerged as a promising target for combined cancer immunotherapy (Vanmeerbeek et al. 2024; Gao et al. 2024).